Novo Nordisk A/S (NOVO-B)の価格はいくらですか

Novo Nordisk A/S (NOVO-B)の価格は$41.14です

Novo Nordisk A/S (NOVO-B)の時価総額は何ですか

Novo Nordisk A/S (NOVO-B)の時価総額は$182.76Bです

Novo Nordisk A/S（NOVO-B）株式分割

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

年	株式分割	分割比率	累積分割比率
2023-09-20	2:1	x2	x200
2014-01-09	5:1	x5	x100
2007-12-17	2:1	x2	x20
2001-04-11	5:2	x2.5	x10
1994-04-18	4:1	x4	x4

年

株式分割

分割比率

累積分割比率

2023-09-20

2:1

x200

2014-01-09

5:1

x100

2007-12-17

2:1

x20

2001-04-11

5:2

x2.5

x10

1994-04-18

4:1

企業	株式分割の回数	累積分割比率	国
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

企業

株式分割の回数

累積分割比率

国